Pomalidomide plus low-dose dexamethasone (POM plus LoDEX) versus high-dose dexamethasone (HiDEX) in relapsed/refractory multiple myeloma (RRMM): Impact of cytogenetics in MM-003

被引：0
|
作者：
Goldschmidt, Hartmut
Dimopoulos, Meletios A.
Weisel, Katja C.
Moreau, Philippe
Lacy, Martha
Song, Kevin W.
Delforge, Michel
Karlin, Lionel
Banos, Anne
Rocafiguera, Albert Oriol
Yu, Xin
Sternas, Lars
Jacques, Christian
Zaki, Mohamed H.
San-Miguel, Jesus F.
机构：
[1] Univ Klinikum Heidelberg, Heidelberg, Germany
[2] Alexandra Hosp, Athens, Greece
[3] Univ Tubingen Hosp, Dept Med, Tubingen, Germany
[4] Hop Hotel Dieu, Univ Hosp, Nantes, France
[5] Mayo Clin, Rochester, MN USA
[6] Vancouver Gen Hosp, Vancouver, BC, Canada
[7] Katholieke Univ Leuven Hosp, Dept Hematol, Louvain, Belgium
[8] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Pierre Benite, France
[9] Ctr Hosp Cote Basque, Bayonne, France
[10] HGTiP, Inst Catala Oncol, Barcelona, Spain
[11] Celgene Corp, Summit, NJ USA
[12] Hosp Univ Salamanca, Salamanca, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8528
引用
收藏
页数：1
相关论文
共 50 条
  • [21] IMPACT OF STABLE DISEASE AS A RESPONSE TO POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE ON SURVIVAL OUTCOMES IN PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA IN THE MM-003 TRIAL
    Moreau, P.
    Weisel, K.
    Song, K.
    Gibson, C.
    Saunders, O.
    Sternas, L.
    Hong, K.
    Zaki, K.
    Dimopoulos, M. A.
    HAEMATOLOGICA, 2015, 100 : 312 - 312
  • [22] Safety and Efficacy of Pomalidomide Plus Low-Dose Dexamethasone (POM plus LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) in Italy: A Subanalysis of the Stratus Trial (MM-010)
    Cavo, Michele
    Corradini, Paolo
    Di Raimondo, Francesco
    Petrini, Mario
    Cafro, Anna Maria
    di Toritto, Tommaso Caravita
    Offidani, Massimo
    Semenzato, Gianpietro
    Zambello, Renato
    Lazzaro, Antonio
    Petrucci, Maria Teresa
    Rodeghiero, Francesco
    Simcock, Mathew
    Slaughter, Ana
    Herring, Jennifer
    Peluso, Teresa
    Palumbo, Antonio
    BLOOD, 2015, 126 (23)
  • [23] An Updated Analysis of the Stratus Trial (MM-010): Safety and Efficacy of Pomalidomide Plus Low-Dose Dexamethasone (POM plus LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
    Dimopoulos, Meletios A.
    Palumbo, Antonio
    Corradini, Paolo
    Cavo, Michele
    Delforge, Michel
    Weisel, Katja C.
    Ocio, Enrique M.
    Di Raimondo, Francesco
    Hansson, Markus
    Simcock, Mathew
    Miller, Neil
    Slaughter, Ana
    Peluso, Teresa
    Sternas, Lars
    Zaki, Mohamed H.
    Moreau, Philippe
    BLOOD, 2015, 126 (23)
  • [24] MM-008 trial: Pharmacokinetics (PK) and tolerability of pomalidomide plus low-dose dexamethasone (POM plus LoDEX) in relapsed/refractory multiple myeloma (RRMM) patients with renal impairment (RI)
    Matous, Jeffrey
    Siegel, David Samuel DiCapua
    Duong, Hien Kim
    Kasserra, Claudia
    Sternas, Lars
    Jacques, Christian
    Klesczewski, Kenneth
    Zaki, Mohamed H.
    Shah, Jatin J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone
    Morgan, Gareth
    Palumbo, Antonio
    Dhanasiri, Sujith
    Lee, Dawn
    Weisel, Katja
    Facon, Thierry
    Delforge, Michel
    Oriol, Albert
    Zaki, Mohamed
    Yu, Xin
    Sternas, Lars
    Jacques, Christian
    Akehurst, Ron
    Offner, Fritz
    Dimopoulos, Meletios A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (06) : 820 - 823
  • [26] Pomalidomide (POM) plus low-dose dexamethasone (LoDEX) plus daratumumab (DARA) in relapsed and/or refractory multiple myeloma (RRMM) after lenalidomide (LEN)-based treatment (Tx) failure.
    Siegel, David Samuel DiCapua
    Schiller, Gary J.
    Samaras, Christy Joy
    Sebag, Michael
    Berdeja, Jesus G.
    Ganguly, Siddhartha
    Matous, Jeffrey
    Song, Kevin W.
    Seet, Christopher
    Talamo, Giampaolo
    Srinivas, Shanthi
    Acosta-Rivera, Mirelis
    Bar, Michael
    Quick, Donald
    Anz, Bertrand Marquess
    Fonseca, Gustavo
    Reece, Donna Ellen
    Zafar, Faiza
    Chung, Weiyuan
    Bahlis, Nizar J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Pomalidomide (POM) with Low-Dose Dexamethasone (LoDEX) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Outcomes Based on Prior Treatment Exposure
    Vij, Ravi
    Hofmeister, Craig C.
    Richardson, Paul G.
    Jagannath, Sundar
    Siegel, David S.
    Baz, Rachid
    Chen, Min
    Zaki, Mohamed
    Larkins, Gail
    Anderson, Kenneth C.
    BLOOD, 2012, 120 (21)
  • [28] IMPACT OF ECOG PERFORMANCE STATUS ON OVERALL SURVIVAL AND HRQOL IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS FROM THE MM-003 TRIAL OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE (DEX) vs HIGH-DOSE DEX
    Weisel, K.
    San Miguel, J.
    Song, K.
    Delforge, M.
    Lewis, P.
    Yu, X.
    Zaki, M.
    Sternas, L.
    Dimopoulos, M.
    HAEMATOLOGICA, 2014, 99 : 518 - 518
  • [29] MM-014: A phase 2 trial evaluating efficacy, safety, and biomarkers of pomalidomide plus low-dose dexamethasone (POM plus LoDEX) is relapsed/refractory multiple myeloma (RRMM) following second-line lenalidomide plus dexamethasone (LEN plus DEX)
    Siegel, David Samuel DiCapua
    Agajanian, Richy
    Gaur, Rakesh
    Karamiou, Kasra
    Kaya, Hakan
    Sturniolo, Michael
    Ricafort, Rosanna J.
    Larkins, Gall
    Srinivasan, Shankar
    Chopra, Rajosh
    Thakurta, Anjan
    Nagarwala, Yasir M.
    Kruter, Flavio
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] PHASE 3 STUDY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: MM-003 SUBANALYSIS OF ELDERLY PATIENTS (> 65 AND > 70 YEARS OF AGE)
    Weisel, K. C.
    San Miguel, J. F.
    Song, K. W.
    Delforge, M.
    Karlin, L.
    Goldschmidt, H.
    Moreau, P.
    Banos, A.
    Oriol, A.
    Garderet, L.
    Cavo, M.
    Ivanova, V.
    Alegre, A.
    Martinez Lopez, J.
    Chen, C. I.
    Knop, S.
    Yu, X.
    Watkins, L.
    Sternas, L.
    Jacques, C.
    Zaki, M. H.
    Dimopoulos, M. A.
    HAEMATOLOGICA, 2014, 99 : 364 - 365
12345